Parkinson’s Disease affects millions of people worldwide. The main symptoms are caused by degeneration of brain cell that control movement. These cell originate in the substantia nigra and communicate with the putamen and caudate.
As this cells degenerate, they lose their ability produce dopamine and to communicate properly with other cells. Current medicines improves Parkinson’s symptoms for several years, but become ineffective as the disease progress.
An experimental bio pharmaceutical drug called (CERE-120) has been safely tested in over 60 people with Parkinson’s disease. CERE-120 is intended to restore damaged dopamine cells and protect them from further degeneration. CERE-120 consists of bio-engineered viral vector, containing only the gene for human nurture and naturally occurring neurotrophic factor.